Ad
related to: fellowships for women in stem cell therapy for autism
Search results
Results from the WOW.Com Content Network
NYSCF was founded in New York City by Susan L. Solomon, a lawyer and entrepreneur, and Mary Elizabeth Bunzel, a former journalist, in 2005 to accelerate stem cell-based approaches to researching and treating type 1 diabetes [3] and in response to the refusal of the administration of President George W. Bush to make a major investment in stem cell research. [1]
This is a list of notable organizations for women in science and, more generally; science, technology, engineering, and math. General STEM-oriented groups.
The Association for Science in Autism Treatment (ASAT) is a non-profit organization devoted to autism. It was founded in 1998 and is currently based in Hoboken, New Jersey . [ 1 ] [ 2 ] Members of its advisory board include Eric Fombonne and Stephen Barrett , [ 3 ] Tristam Smith was one of its board members until his death in August 2018. [ 4 ]
The Autism Science Foundation (ASF) is a non-profit organization that funds evidence-based autism research and supports autism families. [8] The organization was founded in April 2009 by Alison Tepper Singer, a former senior executive of Autism Speaks and the longest-serving public member of the Interagency Autism Coordinating Committee (IACC), and Karen Margulis London, co-founder of the ...
Mesenchymal stem cells and cord blood CD34+ cells have been proposed to treat autism in 2007 [199] and as of 2012 it was thought they may represent a future treatment. [200] Since immune system deregulation has been implicated in autism, mesenchymal stem cells show the greatest promise as treatment for the disorder.
The International Society for Stem Cell Research was formed in 2002 (incorporated on March 30, 2001) to foster the exchange of information on stem cell research. [2] Leonard Zon, professor of pediatrics at Harvard Medical School, served as the organization's first president.
Cell replacement therapy with iPS cells is a possibility. Stem cells can replace diseased or lost cells in degenerative disorders and they are less prone to immune rejection. However, there is a danger that it may introduce mutations or other genomic abnormalities that render it unsuitable for cell therapy.
Maternal immune activation drives Th17 cells to release IL-17a causing cortical defects in offspring and ASD-like behavioral phenotypes Awards 2019 Simons Foundation Autism Research Initiative Awardee, 2018 Peter Gruss Young Investigator Award Winner, 2017 Simons Foundation Autism Research Initiative Pilot Awardee, 2014 Cell’s 40th ...
Ad
related to: fellowships for women in stem cell therapy for autism